Onderneming Innovus Pharmaceuticals Inc OTC Bulletin Board
Aandelen
US45778V1061
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01-06-18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 204 401 | 2 483 540 ( 77,50 %) | 0 | 77,50 % |
Bedrijfsgegevens
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,74% | 723 mld. | |
+34,16% | 595 mld. | |
-2,07% | 369 mld. | |
+20,25% | 332 mld. | |
+2,99% | 282 mld. | |
+17,04% | 244 mld. | |
+9,79% | 208 mld. | |
-4,42% | 205 mld. | |
+2,81% | 168 mld. |